Active not recruitingOBSERVATIONAL

Patients' Follow-up After Subarachnoid Haemorrhage Caused by Ruptured Intracranial Aneurysms

This study is for people who have experienced a type of brain bleed called a subarachnoid haemorrhage, caused by a burst aneurysm, and have received treatment for it. Once an aneurysm has been treated, there's a chance it might grow back or reopen, which could potentially lead to another bleed in the brain. At the moment, doctors don't have much information on how these patients do over a long period. This research aims to gather detailed information about people's health and recovery in the years following their treatment. This will help doctors better understand the long-term effects and improve the care provided to similar patients in the future, ensuring they receive the best possible support and monitoring.

At a glance

Status

Active not recruiting

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Enrolment target

400

Start

08 Sep 2016

Estimated completion

01 Jan 2032

Intracranial Aneurysms

What is this study about?

This study focuses on individuals who have had a serious condition called a subarachnoid haemorrhage. This happens when a weak spot in a blood vessel in the brain, called an aneurysm, bursts and causes bleeding around the brain. These aneurysms are often treated with a procedure called embolisation, which involves using tiny coils or glue to block off the aneurysm and prevent further bleeding.

While embolisation is effective, sometimes the treated aneurysm can partially reopen or even regrow over time. If this happens, there's a risk of another brain bleed, which can be very serious. Doctors currently don't have much information about how patients fare in the many years after they've had this type of brain bleed and treatment. This research aims to fill that knowledge gap.

The main goal of this study is to carefully follow up with patients after their treatment. Researchers want to observe how people recover over the long term, understand if the treated aneurysms remain stable, and identify any potential risks of issues returning. By gathering this important information, doctors can develop better long-term care plans and provide more accurate advice to future patients who experience similar brain bleeds, ultimately improving their health and wellbeing.

Key takeaways

This study explores long-term health after a specific type of brain bleed.
It focuses on patients treated for a burst brain aneurysm.
Researchers want to know if treated aneurysms might reappear.
The goal is to improve future care for similar patients.
Participation contributes to important medical knowledge.
The study likely uses existing medical records for information.

Who may be eligible?

To be considered for this study, you must have previously had a brain bleed (subarachnoid haemorrhage) that was caused by a burst aneurysm. This aneurysm must have been treated using a procedure called embolisation.

This study is open to both men and women of all adult ages. Children are not eligible for this study. If you have been treated for a brain aneurysm using a method other than embolisation, or if your brain bleed was caused by something else, this study is not for you.

It's important that you are willing to take part in the study. If you prefer not to participate, that's perfectly fine, and you won't be able to join the study.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Have you had a brain bleed called a subarachnoid haemorrhage?
Was your brain bleed caused by a burst aneurysm?
Was your aneurysm treated with a procedure called embolisation?
Are you willing to participate in a research study?
Are you of adult age (not a child)?

Answer every question to see your result.

What does participation involve?

The information provided does not detail specific visits, assessments, medication, or the exact duration of follow-up for this study. However, generally in studies like this, taking part would involve following up with your medical team. This might include attending regular appointments where doctors review your medical records, possibly ask you questions about your health and recovery, and might look at past brain scans. It's likely that the study aims to collect information that is already part of your routine medical care after such a condition, rather than asking you to undergo new or additional procedures. The goal is often to track your health progress over an extended period.

Potential risks and benefits

A potential benefit of joining this study is that you would be contributing valuable information that could improve care for future patients with similar conditions. There are no direct medical benefits to you personally, as the study focuses on observing your long-term health rather than providing a new treatment. Based on the available information, risks are expected to be very low, as the study appears to involve data collection from your existing medical records or routine follow-up appointments, rather than new procedures or treatments. You have the right to withdraw from the study at any time without affecting your medical care.

Locations (1)

Fondation Opthalmologique A de Rothschild
Verified postcode
Paris, France

Common questions

What is a subarachnoid haemorrhage?

It's a type of bleeding that happens in the space between the brain and the tissues covering it, often caused by a burst blood vessel.

What is an intracranial aneurysm?

It's a weak, bulging spot in the wall of a blood vessel in the brain, like a tiny balloon, which can sometimes burst.

What does 'endovascular treatment' mean?

It's a type of treatment that doctors perform from inside your blood vessels, often using a thin tube called a catheter to reach the problem area, like coiling an aneurysm.

What does 'recanalization' mean?

It means that a blood vessel or an aneurysm that was previously treated (like being blocked off) has partly reopened.

Will taking part in this study give me new medication?

No, this study focuses on understanding recovery and long-term outcomes after standard treatment, not testing new medications.